Abstract:Objective To investigate the efficacy of pulsed radiofrequency combined with pregabalin in the treatment of postherpetic neuralgia and its effects on serum inflammatory factors and immune levels.?Methods?A total of 100 patients with postherpetic neuralgia admitted to our hospital from November 2019 to December 2020 were selected as the study subjects and randomly divided into the observation group (n?=?50 patients, pulsed radiofrequency combined with pregabalin therapy) and control group (n?=?50 patients, pulsed radiofrequency therapy). Visual Analogue Scale (VAS) and Pittsburgh Sleep Quality Index (PSQI) were used to evaluate the pain and sleep quality of the two groups before and after treatment. Levels of the serum pain mediators, including serum β-endorphin (β-EP), neurotensin (NT), calcitonin gene-related peptide (CGRP), and nerve growth factor inducible protein (VGF), as well as the levels of the serum inflammatory factors which included tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8) and C-reactive protein (CRP) of the two groups were measured by enzyme-linked immunosorbent assay (ELISA) before and after treatment. Serum levels of C3, C4, IgG, IgA and IgM were measured by immune scatter turbidimetry. The contents of CD3+, CD4+, and CD8+, as well as the levels of NK cells before and after treatment were measured by FACS Calibur flow cytometer, and the CD4+/CD8+ ratio was calculated based on the value.?Results?The differences in VAS and PSQI scores before and after treatment were higher in the observation group than those in the control group (P < 0.05). The differences in serum pain mediators, inflammatory factors and immunoglobulin before and after treatment in the observation group were also greater than those in the control group (P < 0.05). Additionally, the differences in levels of CD3+, CD4+, CD4+/CD8+ ratio and NK cells before and after treatment in the observation group were as well larger than those in the control group (P?0.05).?Conclusions?Pulsed radiofrequency combined with pregabalin in the treatment of postherpetic neuralgia can effectively relieve the pain, improve the sleep quality of the patients, reduce the inflammatory response and promote the recovery of immune function.